SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Medicines Co/DE – ‘S-3ASR’ on 8/12/13 – EX-12

On:  Monday, 8/12/13, at 4:12pm ET   ·   Effective:  8/12/13   ·   Accession #:  1047469-13-8368   ·   File #:  333-190568

Previous ‘S-3ASR’:  ‘S-3ASR’ on 1/16/07   ·   Next:  ‘S-3ASR’ on 3/4/16   ·   Latest:  ‘S-3ASR’ on 6/24/19

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 8/12/13  Medicines Co/DE                   S-3ASR      8/12/13   10:1.4M                                   Merrill Corp/New/FA

Automatic Shelf Registration Statement for Securities of a Well-Known Seasoned Issuer   —   Form S-3
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-3ASR      Automatic Shelf Registration Statement for          HTML    253K 
                          Securities of a Well-Known Seasoned                    
                          Issuer                                                 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML    356K 
 3: EX-4.2      Instrument Defining the Rights of Security Holders  HTML    373K 
 4: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     48K 
 5: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     48K 
 6: EX-5.1      Opinion re: Legality                                HTML     46K 
 7: EX-12       Statement re: Computation of Ratios                 HTML     16K 
 8: EX-23.1     Consent of Experts or Counsel                       HTML      8K 
 9: EX-23.2     Consent of Experts or Counsel                       HTML      8K 
10: EX-23.3     Consent of Experts or Counsel                       HTML      8K 


EX-12   —   Statement re: Computation of Ratios


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




Exhibit 12

 

CONSOLIDATED RATIOS OF EARNINGS TO FIXED CHARGES

 

The following table sets forth our ratio of earnings to fixed charges for each of the periods indicated.  You should read this table in conjunction with the consolidated financial statements and notes incorporated by reference in this prospectus.

 

 

 

Six Months
Ended

 

Fiscal Year Ended

 

 

 

June 30,
2013

 

December 31,
2012

 

December 31,
2011

 

December 31,
2010

 

December 31,
2009

 

December 31,
2008

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated ratios of earnings to fixed charges

 

2

 

10

 

35

 

34

 

 

 

 

For purposes of calculating the ratios in the table above, earnings consist of income from continuing operations before provision for taxes on income less noncontrolling interests. “Fixed charges” consist of interest expense, which includes amortization of debt premium, discount and other debt costs, one-third of rental expense, which we believe to be a conservative estimate of an interest factor in our leases, which are not material, and capitalized interest. The ratio was calculated by dividing the sum of the earnings (as defined above) by the sum of the fixed charges (as defined above). For the years ended December 31, 2008 and 2009, our pre-tax losses were $5.6 million and $28.2 million, respectively, and were insufficient to cover fixed charges for those periods.

 




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘S-3ASR’ Filing    Date    Other Filings
Filed on / Effective on:8/12/13424B5,  8-K
6/30/1310-Q
12/31/1210-K,  5
12/31/1110-K/A
12/31/1010-K,  10-K/A
12/31/0910-K
12/31/0810-K
 List all Filings 
Top
Filing Submission 0001047469-13-008368   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 3, 6:57:33.1pm ET